In This Article:
We recently published a list of Top 20 Falling Stocks with Unusual Volume. In this article, we are going to take a look at where Neogen Corporation (NASDAQ:NEOG) stands against other top falling stocks with unusual volume.
Uncertainty around tariffs and macroeconomic conditions has dented investor confidence, resulting in stock prices falling. While some stocks have come under pressure due to the above two reasons, others have simply followed the market direction or have dipped for company-specific reasons.
Regardless of the reasons for stocks going down, falling stocks provide an opportunity for fresh investors to get in at good prices. Once the risks subside, these stocks usually recover quickly as well. We decided to uncover these stocks and see if it makes sense to put money in them to take advantage of the ongoing market turmoil.
To come up with our list of top 20 stocks falling with unusual volume, we looked at stocks over $300 million in market cap, their one-week performance, and used relative volume to detect the unusual volume activity.
Relative volume compares the daily volume to the three-month average trading volume of the stock, making it easy to detect spikes in volume. These spikes usually signal something important is happening, which, when combined with falling prices, becomes a red flag that investors can’t ignore.
A research laboratory showing advanced diagnostic equipment used to protect public health.
Neogen Corporation (NASDAQ:NEOG)
Neogen Corporation (NASDAQ:NEOG) is the manufacturer, developer, and marketer of different products and services focused on animal and food safety. The company operates in the Animal Safety and Food Safety segments. The stock is down 22.02% in a week on a relative volume of 2.69.
Neogen missed both revenue and Non-GAAP EPS estimates in Q3. Revenue declined by 3.4% YoY while non-GAAP EPS missed by $0.02. The company lowered its Q4 2025 guidance due to the lower-than-expected third quarter results. As per the updated revenue guidance, the firm now projects Q4 revenue to be approximately $895 million. Expected capital expenditures are $100 million with adjusted EBITDA of about $195 million.
At the start of this month, Neogen Corporation (NASDAQ:NEOG) announced the successful refinancing of its debt. As per the new agreement, a $250 million revolving credit facility and a $450 million term loan have a maturity date of August 2027. With the help of this new deal, the maturity date has been extended by over two and a half years.
CFO and COO of Neogen Corporation (NASDAQ:NEOG), David Naemura, said: